Bluestar Adisseo (600299): Good growth of methionine, continuous capacity expansion to consolidate its leading position.
Bluestar Adisseo releases its 2024 interim report: in the first half of 2024, it achieved revenue of 7.261 billion yuan, YoY +14.74%, and net income attributable to the parent company of 0.608 billion yuan, YoY +1719.14%. The main product is eggs.
Bluestar Adisseo H1 Profit Surges 18-Fold; Shares Down 3%
Andisu 2024 Semi-Annual Report
Andisu 2024 Semi-Annual Report Summary
Bluestar Adisseo (600299.SH): net income in the first half of the year was 0.608 billion yuan, a year-on-year increase of 1719.14%.
Bluestar Adisseo (600299.SH) announced its semi-annual report for 2024, achieving a revenue of 7.261 billion yuan in the first half of the year, a year-on-year increase of 14.74%; achieving a net income attributable to shareholders of listed companies of 0.608 billion yuan, a year-on-year increase of 1,719.14%; achieving a net income attributable to shareholders of listed companies after deducting non-recurring gains and losses of 0.705 billion yuan, a year-on-year increase of 6,522.57%; basic earnings per share of 0.23 yuan. In the first half of 2024, the net income attributable to shareholders of listed companies and the net income attributable to shareholders of listed companies after deducting non-recurring gains and losses
Express News | Bluestar Adisseo: The net income attributable to shareholders in the first half of the year was 0.608 billion yuan, a year-on-year increase of 1719.14%.
Bluestar Adisseo (600299.SH): net income of 0.608 billion yuan in the first half of the year, a year-on-year increase of 1719.14%.
Bluestar Adisseo (600299.SH) announced its semi-annual report with a revenue of 7.26 billion yuan, a year-on-year growth of 14.74%, a net income of 0.608 billion yuan, a year-on-year growth of 1719.14%, a non-GAAP net income of 0.705 billion yuan, a year-on-year growth of 6,522.57%, and an EPS of 0.23 yuan.
Express News | Bluestar Adisseo: Net income in the first half of the year increased by 1719.14% year-on-year.
Express News | Sealand Securities: Vitamins' prosperity accelerates upward.
Express News | Delivery of some vitamin products from BASF has been affected by force majeure. Concept stocks have surged and over 10 listed companies have responded to their related business layout.
Bluestar Adisseo (600299.SH) will pay a dividend of 0.06 yuan per share for the year 2023, with a registration date of August 12th.
Bluestar Adisseo (600299.SH) announced that the company will implement the annual equity distribution for the year 2023, with a distribution of... per share.
Express News | 4950 A-share listed companies have released their performance forecast for the first half of 2024. Anli Material Technology has the highest net profit, with a year-on-year increase of 10421%.
Express News | 1486 A-share listed companies have released their half-year performance forecasts for 2024, with 24 companies expected to achieve a maximum year-on-year net profit growth of over 700%.
Bluestar Adisseo (600299): strong growth in methionine business, Q2 performance significantly increased.
Event: The company released its 2024 interim performance forecast, with an expected net income attributable to shareholders of 550-650 million yuan, a year-on-year increase of +1547%~+1846%, achieving a non-GAAP net income attributable to shareholders.
Bluestar Adisseo's half-year performance is expected to increase in 2024 according to the announcement.
Bluestar Adisseo (600299.SH) announced a profit increase, with net income for the first half of the year reaching 0.55 billion to 0.65 billion yuan, a staggering increase of 1546.71% to 1846.11%.
Bluestar Adisseo (600299.SH) released a performance forecast for the first half of 2024, and the company expects the attributable...
Express News | Bluestar Adisseo: Net profit is expected to grow by 1546%-1846% year on year in the first half of the year.
Express News | Bluestar Adisseo: Deputy General Manager Resigns.
Andisu (600299): High Q1 performance, continuous expansion of production capacity, steady development of the two pillars
Core idea In the first quarter of 2024, the company achieved revenue of 3.496 billion yuan, a year-on-year increase of 10.90%, achieved net profit of 277 million yuan, an increase of 185 12.09% over the previous year, and achieved a net profit of 3.79 billion yuan without deduction to mother
Andisu (600299.SH): Continuing to strengthen collaboration in synthetic biology research
Gelonghui, May 9丨Andy Su (600299.SH) said on an interactive platform that speeding up the development of the specialty products business is one of the keys to the “double pillar” strategy. By optimizing the layout of specialty products on a global scale, the company enhances the cost competitiveness, supply flexibility, customer response speed and level of sustainable development of specialty product supply. Every year, the company invests a large amount of R&D funds in the field of specialty products to ensure the launch of new specialty products and related services through various methods such as internal innovation and external strategic cooperation, while further developing and strengthening marketing products and services. Since 2014, the company has
No Data
No Data